A single blind study to compare nebulised hypertonic saline (7%) and normal saline (0.9%) as an adjunct to physiotherapy airway clearance in patients with bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 304s Year: 2005
Hyaluronic acid improves tolerability to 7% hypertonic saline solution in bronchiectasis patients Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018
Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010
Clinical surveys with nebulised hypertonic saline (HS) in CF children Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020
The effect of cetylpridinium chloride and NaOH %0.3 to isolation of tuberculosis in sputum Source: Annual Congress 2007 - Diagnosis and treatment of drug susceptible and resistant tuberculosis Year: 2007
Effects of intrabronchial terlipressin versus cold normal saline solution application in endobronchial bleeding Source: Annual Congress 2007 - Therapeutic bronchoscopy Year: 2007
Analysis of solubilization time of human bronchial mucus in isotonic saline solution through photoacoustic technique Source: Eur Respir J 2005; 26: Suppl. 49, 485s Year: 2005
Respiratory symptoms and sensitisation in subjects exposed to sodium bisulfite treated (1% solution) Norwegian lobsters Source: Eur Respir J 2003; 22: Suppl. 45, 489s Year: 2003
Efficacy of hypertonic saline solution in infant with acute bronchiolitis Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007
A Comparison of 2% lidocaine viscous versus 2% lidocaine solution for improving discomfort and satisfaction in patients undergoing flexible bronchoscopy Source: International Congress 2017 – Nursing practice across respiratory care pathways Year: 2017
Effect of inhaled hypertonic saline solution to treat infants hospitalized with viral bronchiolitis Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011
Comparison of tobramycin 80 mg (IV-Preparation) and 300 mg solution for inhalation in cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 620s Year: 2005
The in vitro effect of nebulised hypertonic saline on human bronchial epithelium Source: Eur Respir J, 51 (5) 1702652; 10.1183/13993003.02652-2017 Year: 2018
Safety and efficacy of 7% hypertonic saline in patients with bronchiectasis Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013
7% hypertonic saline and hyaluronic acid and in the treatment of infants mild-moderate bronchiolitis Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011
Prevalence of bronchoconstriction in patients with bronchiectasis assessed prior to treatment with a dry powder preparation of mannitol Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Inhalation therapy with hypertonic saline (3%) – A treatment option for airway disease in children? Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015
Effect of 3 different nebulisers on the aerosol delivery performance of isotonic disodium comoglycate (IsoCROM) Source: Eur Respir J 2006; 28: Suppl. 50, 212s Year: 2006
Effects on the respirable dose < 3.3 µm of an isotonic DSCG inhalation solution (IsoCROM) comparing different nebuliser systems mimicking 3 year old childrens' breathing patterns Source: Eur Respir J 2007; 30: Suppl. 51, 460s Year: 2007
Oxygen saturation decrease after both isotonic and hypertonic saline inhalation in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 698s Year: 2005